The use of eye-tracking technology as a tool to evaluate social cognition in people with an intellectual disability: a systematic review and meta-analysis.
Autism
Eye-tracking
Genetic syndromes
Intellectual disability
Social cognition
Journal
Journal of neurodevelopmental disorders
ISSN: 1866-1955
Titre abrégé: J Neurodev Disord
Pays: England
ID NLM: 101483832
Informations de publication
Date de publication:
04 Dec 2023
04 Dec 2023
Historique:
received:
24
04
2023
accepted:
25
10
2023
medline:
5
12
2023
pubmed:
4
12
2023
entrez:
3
12
2023
Statut:
epublish
Résumé
Relatively little is known about social cognition in people with intellectual disability (ID), and how this may support understanding of co-occurring autism. A limitation of previous research is that traditional social-cognitive tasks place a demand on domain-general cognition and language abilities. These tasks are not suitable for people with ID and lack the sensitivity to detect subtle social-cognitive processes. In autism research, eye-tracking technology has offered an effective method of evaluating social cognition-indicating associations between visual social attention and autism characteristics. The present systematic review synthesised research which has used eye-tracking technology to study social cognition in ID. A meta-analysis was used to explore whether visual attention on socially salient regions (SSRs) of stimuli during these tasks correlated with degree of autism characteristics presented on clinical assessment tools. Searches were conducted using four databases, research mailing lists, and citation tracking. Following in-depth screening and exclusion of studies with low methodological quality, 49 articles were included in the review. A correlational meta-analysis was run on Pearson's r values obtained from twelve studies, reporting the relationship between visual attention on SSRs and autism characteristics. Eye-tracking technology was used to measure different social-cognitive abilities across a range of syndromic and non-syndromic ID groups. Restricted scan paths and eye-region avoidance appeared to impact people's ability to make explicit inferences about mental states and social cues. Readiness to attend to social stimuli also varied depending on social content and degree of familiarity. A meta-analysis using a random effects model revealed a significant negative correlation (r = -.28, [95% CI -.47, -.08]) between visual attention on SSRs and autism characteristics across ID groups. Together, these findings highlight how eye-tracking can be used as an accessible tool to measure more subtle social-cognitive processes, which appear to reflect variability in observable behaviour. Further research is needed to be able to explore additional covariates (e.g. ID severity, ADHD, anxiety) which may be related to visual attention on SSRs, to different degrees within syndromic and non-syndromic ID groups, in order to determine the specificity of the association with autism characteristics.
Sections du résumé
BACKGROUND
BACKGROUND
Relatively little is known about social cognition in people with intellectual disability (ID), and how this may support understanding of co-occurring autism. A limitation of previous research is that traditional social-cognitive tasks place a demand on domain-general cognition and language abilities. These tasks are not suitable for people with ID and lack the sensitivity to detect subtle social-cognitive processes. In autism research, eye-tracking technology has offered an effective method of evaluating social cognition-indicating associations between visual social attention and autism characteristics. The present systematic review synthesised research which has used eye-tracking technology to study social cognition in ID. A meta-analysis was used to explore whether visual attention on socially salient regions (SSRs) of stimuli during these tasks correlated with degree of autism characteristics presented on clinical assessment tools.
METHOD
METHODS
Searches were conducted using four databases, research mailing lists, and citation tracking. Following in-depth screening and exclusion of studies with low methodological quality, 49 articles were included in the review. A correlational meta-analysis was run on Pearson's r values obtained from twelve studies, reporting the relationship between visual attention on SSRs and autism characteristics.
RESULTS AND CONCLUSIONS
CONCLUSIONS
Eye-tracking technology was used to measure different social-cognitive abilities across a range of syndromic and non-syndromic ID groups. Restricted scan paths and eye-region avoidance appeared to impact people's ability to make explicit inferences about mental states and social cues. Readiness to attend to social stimuli also varied depending on social content and degree of familiarity. A meta-analysis using a random effects model revealed a significant negative correlation (r = -.28, [95% CI -.47, -.08]) between visual attention on SSRs and autism characteristics across ID groups. Together, these findings highlight how eye-tracking can be used as an accessible tool to measure more subtle social-cognitive processes, which appear to reflect variability in observable behaviour. Further research is needed to be able to explore additional covariates (e.g. ID severity, ADHD, anxiety) which may be related to visual attention on SSRs, to different degrees within syndromic and non-syndromic ID groups, in order to determine the specificity of the association with autism characteristics.
Identifiants
pubmed: 38044457
doi: 10.1186/s11689-023-09506-9
pii: 10.1186/s11689-023-09506-9
pmc: PMC10694880
doi:
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
42Informations de copyright
© 2023. The Author(s).
Références
J Neurodev Disord. 2019 Jan 21;11(1):1
pubmed: 30665413
Lancet Psychiatry. 2015 Oct;2(10):909-16
pubmed: 26341300
Stud Health Technol Inform. 2015;217:63-70
pubmed: 26294454
Autism Res. 2014 Aug;7(4):433-41
pubmed: 24664986
Mol Autism. 2023 Jan 13;14(1):3
pubmed: 36639821
Vision Res. 2015 Feb;107:124-32
pubmed: 25542277
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
J Autism Dev Disord. 2014 Mar;44(3):584-92
pubmed: 23918441
J Neurodev Disord. 2017 Mar 3;9:8
pubmed: 28270868
J Autism Dev Disord. 2011 Nov;41(11):1515-22
pubmed: 21267642
J Intellect Disabil Res. 2016 Apr;60(4):308-321
pubmed: 26762203
Pediatr Neurol. 2021 Jan;114:21-25
pubmed: 33189026
Cognition. 1983 Jan;13(1):103-28
pubmed: 6681741
J Autism Dev Disord. 2016 Jun;46(6):2148-2159
pubmed: 26983920
Autism. 2016 May;20(4):442-62
pubmed: 26134030
PLoS One. 2015 Oct 01;10(10):e0139319
pubmed: 26426329
J Autism Dev Disord. 2020 Dec;50(12):4412-4430
pubmed: 32279223
Mol Autism. 2016 Sep 07;7(1):40
pubmed: 27610215
Res Dev Disabil. 2013 Dec;34(12):4608-16
pubmed: 24210355
Autism Res. 2014 Feb;7(1):72-83
pubmed: 24124133
Arq Neuropsiquiatr. 2015 May;73(5):402-7
pubmed: 26017205
Mol Autism. 2022 May 4;13(1):18
pubmed: 35509089
Arch Gen Psychiatry. 2008 Aug;65(8):946-54
pubmed: 18678799
Trends Cogn Sci. 2000 Jul;4(7):267-278
pubmed: 10859571
Autism Res. 2020 Feb;13(2):259-270
pubmed: 31419075
Autism Res. 2013 Dec;6(6):468-78
pubmed: 24124067
Int J Epidemiol. 2008 Oct;37(5):1158-60
pubmed: 18832388
Front Psychol. 2012 Jun 25;3:197
pubmed: 22737137
Autism Res. 2019 Oct;12(10):1529-1540
pubmed: 31369217
Front Psychol. 2016 Sep 13;7:1363
pubmed: 27679588
Int J Dev Neurosci. 2005 Apr-May;23(2-3):125-41
pubmed: 15749240
Orphanet J Rare Dis. 2019 Nov 15;14(1):262
pubmed: 31730500
Epidemiol Psychiatr Sci. 2021 Dec 02;30:e78
pubmed: 34852862
Autism. 2014 Jan;18(1):17-30
pubmed: 24126870
J Neurodev Disord. 2017 Sep 25;9(1):9
pubmed: 28946865
Mol Autism. 2022 Mar 21;13(1):15
pubmed: 35313957
Ment Retard Dev Disabil Res Rev. 2004;10(4):259-71
pubmed: 15666336
J Inherit Metab Dis. 2013 Mar;36(2):189-200
pubmed: 23385295
Biol Psychiatry. 2019 Oct 15;86(8):631-638
pubmed: 31262432
J Neurodev Disord. 2015;7(1):22
pubmed: 26229571
Front Pediatr. 2018 May 03;6:102
pubmed: 29774207
Dev Med Child Neurol. 2021 May;63(5):527-536
pubmed: 33452688
Dev Sci. 2020 Nov;23(6):e12961
pubmed: 32154971
Neuropsychologia. 2008 Sep;46(11):2855-60
pubmed: 18561959
Dev Med Child Neurol. 2019 Nov;61(11):1266-1274
pubmed: 31074506
J Autism Dev Disord. 2021 Aug;51(8):2578-2599
pubmed: 33011860
Dev Psychol. 2013 Jan;49(1):59-71
pubmed: 22545843
Psychol Med. 2011 Mar;41(3):619-27
pubmed: 21272389
Cortex. 2020 Nov;132:99-112
pubmed: 32971481
Am J Med Genet B Neuropsychiatr Genet. 2013 Jun;162B(4):327-66
pubmed: 23650212
Am J Med Genet A. 2022 Sep;188(9):2536-2554
pubmed: 35730128
Am J Intellect Dev Disabil. 2015 Jul;120(4):328-45
pubmed: 26161470
J Intellect Disabil Res. 2016 Oct;60(10):969-81
pubmed: 27476718
J Clin Epidemiol. 2016 Jul;75:40-6
pubmed: 27005575
J Autism Dev Disord. 2017 Jun;47(6):1866-1877
pubmed: 28349363
Autism. 2007 May;11(3):265-77
pubmed: 17478579
J Autism Dev Disord. 2014 May;44(5):1220-9
pubmed: 24197115
J Speech Lang Hear Res. 2018 May 17;61(5):1157-1170
pubmed: 29710313
Psychiatry Res. 2011 Sep 30;189(2):292-8
pubmed: 21831452
J Neurodev Disord. 2016 Oct 24;8:38
pubmed: 27795743
Dev Psychol. 2014 Mar;50(3):903-913
pubmed: 23978296
J Autism Dev Disord. 2013 May;43(5):1119-39
pubmed: 23015109
Transl Psychiatry. 2018 Aug 8;8(1):146
pubmed: 30089781
Res Dev Disabil. 2016 Jan;48:79-93
pubmed: 26547134
Psychiatry Res. 2010 May 15;177(1-2):211-5
pubmed: 20381171
Cognition. 2017 Apr;161:10-18
pubmed: 28088702
J Am Acad Child Adolesc Psychiatry. 2010 Jul;49(7):665-74
pubmed: 20610136
Autism. 2020 Apr;24(3):658-669
pubmed: 31647314
Mol Autism. 2016 Apr 05;7:24
pubmed: 27054022
Autism. 2013 Nov;17(6):655-67
pubmed: 22987889
J Neurodev Disord. 2021 Dec 4;13(1):58
pubmed: 34863106
J Intellect Disabil Res. 2009 Feb;53(2):169-81
pubmed: 19192099
Science. 2009 Aug 14;325(5942):883-5
pubmed: 19608858
Autism. 2014 Aug;18(6):684-93
pubmed: 24104519
Augment Altern Commun. 2014 Jun;30(2):130-46
pubmed: 24773517
Autism Res. 2019 May;12(5):779-793
pubmed: 30891960
J Abnorm Child Psychol. 2007 Feb;35(1):17-28
pubmed: 17123170
Res Dev Disabil. 2014 Nov;35(11):2658-72
pubmed: 25062097
Curr Dev Disord Rep. 2023;10(2):132-146
pubmed: 37193200
J Autism Dev Disord. 2020 Jan;50(1):127-144
pubmed: 31541420
J Autism Dev Disord. 2023 Jul;53(7):2786-2797
pubmed: 35445369
Mol Autism. 2019 Mar 1;10:9
pubmed: 30867896
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
Am J Med Genet B Neuropsychiatr Genet. 2020 Jan;183(1):5-16
pubmed: 31418535
Nature. 2013 Dec 19;504(7480):427-31
pubmed: 24196715
Autism Res. 2008 Feb;1(1):31-42
pubmed: 19360648
Dev Med Child Neurol. 2013 Apr;55(4):364-71
pubmed: 23488948
J Autism Dev Disord. 2013 Aug;43(8):1926-34
pubmed: 23292161
Res Dev Disabil. 2015 Oct-Nov;45-46:202-9
pubmed: 26263406
Autism Res. 2019 May;12(5):766-778
pubmed: 30770676
Int J Dev Disabil. 2020 Sep 10;68(4):399-415
pubmed: 35937179
Autism. 2015 May;19(4):459-68
pubmed: 24627427
J Autism Dev Disord. 2009 Jun;39(6):946-52
pubmed: 19399604
J Intellect Disabil Res. 2009 Oct;53(10):852-73
pubmed: 19708861
Res Dev Disabil. 2013 Dec;34(12):4466-76
pubmed: 24139712
J Learn Disabil. 2005 Jan-Feb;38(1):45-61
pubmed: 15727328
Neuroscientist. 2012 Apr;18(2):108-13
pubmed: 21609942
Biol Psychiatry. 2013 Aug 1;74(3):195-203
pubmed: 23313640
J Physiol. 2007 Jun 15;581(Pt 3):893-8
pubmed: 17430985
Epidemiology. 2008 Jan;19(1):94-100
pubmed: 18090860
Res Autism Spectr Disord. 2017 Mar;35:25-34
pubmed: 28839456
J Appl Res Intellect Disabil. 2020 Mar;33(2):126-138
pubmed: 31430018
Autism Adulthood. 2021 Mar 1;3(1):18-29
pubmed: 36601265
J Clin Exp Neuropsychol. 2022 Dec;44(10):755-767
pubmed: 36694386
J Am Acad Child Adolesc Psychiatry. 2017 Jul;56(7):546-555
pubmed: 28647006
Res Dev Disabil. 2020 Sep;104:103693
pubmed: 32505967
J Autism Dev Disord. 2009 Mar;39(3):421-31
pubmed: 18787936
Neurosci Biobehav Rev. 2014 May;42:279-97
pubmed: 24694721
Res Dev Disabil. 2017 Sep;68:88-94
pubmed: 28750207
J Neurodev Disord. 2018 Aug 29;10(1):26
pubmed: 30157749
Int J Surg. 2021 Apr;88:105906
pubmed: 33789826
Pediatr Neurol. 2014 Nov;51(5):650-6
pubmed: 25217338
Behav Res Methods. 2023 Jan;55(1):364-416
pubmed: 35384605
Psychon Bull Rev. 2015 Feb;22(1):1-12
pubmed: 24847901
Soc Cogn Affect Neurosci. 2006 Dec;1(3):175-82
pubmed: 18985104
J Autism Dev Disord. 2013 Aug;43(8):1880-94
pubmed: 23224515
Curr Opin Psychiatry. 2016 Mar;29(2):95-102
pubmed: 26779862
Am J Med Genet B Neuropsychiatr Genet. 2015 Oct;168(7):564-72
pubmed: 26079280
Front Psychiatry. 2019 Jun 19;10:426
pubmed: 31275179
Autism Res. 2008 Aug;1(4):231-9
pubmed: 19360673
J Autism Dev Disord. 2020 Nov;50(11):3988-4000
pubmed: 32189228
J Neurodev Disord. 2013 May 10;5(1):13
pubmed: 23663405
Autism. 2017 Oct;21(7):852-861
pubmed: 27354431
Cogn Neuropsychiatry. 2010 Nov;15(6):505-30
pubmed: 20432078
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120